Starling Oncology Inc. Wt

Starling Oncology Inc. Wt

STLNW

Get informed when a big investor buys or sells

+ Follow
Market Cap$436.37M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Starling Oncology Inc. WtStarling Oncology Inc. Wt0-146%--4.3

Share Statistics

Market cap$436.37 Million
Enterprise Value$501.91 Million
Dividend Yield$NaN (NaN%)
Earnings per Share$-
Beta-
Outstanding Shares-

Return

Return on Equity145.67%ROE
Return on Assets-20.36%
Return on Invested Capital-35.30%

Valuation & Multiples

P/E Ratio-P/E Ratio
PEG-PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.85
Enterprise Value to EBIT-17.07
Enterprise Value to Net Income-14
Total Debt to Enterprise0.21
Debt to Equity-4.28Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$-0.06
Average shareholder expectation
Revenue Estimate
$155.74 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 11, 2026
EPS Estimate
$-0.05
Average shareholder expectation
Revenue Estimate
$168.69 M
Average shareholder expectation

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About DFP Healthcare Acquisitions Corp

641 employees
CEO: Daniel Virnich

DFP Healthcare Acquisitions Corp. is a blank check company. The Company’s business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more ...